TPX-100: OrthoTrophix Presents New Data Revealing Structural Coupling between Femoral Bone Shape and Meniscal Pathology in Knee Osteoarthritis

FOSTER CITY, Calif., April 24, 2026 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced new clinical data demonstrating a significant association between femoral subchondral bone shape, measured by B-score, and meniscal pathology in patients...